You are here

Article Text

Article menu
Download PDFPDF
Archimedes
What dose of aspirin should be used in the initial treatment of Kawasaki disease?
  1. Luke Guo Yang Ho1,2,
  2. Nigel Curtis2
  1. 1 Monash School of Medicine, Monash University, Clayton, Victoria, Australia
  2. 2 Department of Paediatrics, The University of Melbourne and Murdoch Children’s Research Institute, The Royal Children’s Hospital Melbourne, Parkville, Victoria, Australia
  1. Correspondence to Professor Nigel Curtis, Department of Paediatrics, The University of Melbourne, The Royal Children’s Hospital Melbourne, Flemington Road Parkville, VIC 3052; Nigel.Curtis{at}rch.org.au

https://doi.org/10.1136/archdischild-2017-313538

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Scenario

    You are looking after a previously well child recently diagnosed with Kawasaki disease (KD). You start him on intravenous immunoglobulin (IVIG) and are about to start him on aspirin. Knowing the potential adverse effects of aspirin, you wonder whether low-dose aspirin is as effective as high-dose aspirin to prevent coronary artery complications.

    Structured clinical question

    In a child with KD (patient), is low-dose aspirin (intervention) as effective as high-dose aspirin (control) in reducing the risk of coronary artery complications (outcome) when used with IVIG.

    Search strategy and outcome

    PubMed and Medline (Ovid, 1946–present) were searched in June 2017 using the following keywords: Kawasaki AND (aspirin OR salicyl* OR ASA) AND (dose OR dosage). Results were limited to those published in English. Case reports and small case series were excluded, as were studies in which patients were not treated with IVIG and those that did not compare different aspirin doses (including a low ‘anti-thrombotic’ dose) within the same study. This identified 333 articles, of which six were relevant (table 1). A hand search of these publications (and those listed …

    View Full Text

    Footnotes

    • Handling editor Martin Ward Platt

    • Contributors LGYH was the main author and researcher. NC was the main editor, providing guidance towards structure, writing style and additional resources.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles